Neuroone Research Development from 2010 to 2026
| NMTC Stock | USD 0.85 0.02 2.47% |
Research Development | First Reported 2017-03-31 | Previous Quarter 1.2 M | Current Value 1.1 M | Quarterly Volatility 537.2 K |
Check Neuroone Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuroone Medical's main balance sheet or income statement drivers, such as Interest Expense of 675.2 K, Selling General Administrative of 8.9 M or Total Revenue of 14.6 M, as well as many indicators such as Price To Sales Ratio of 28.9 K, Dividend Yield of 0.0 or Days Sales Outstanding of 62.36. Neuroone financial statements analysis is a perfect complement when working with Neuroone Medical Valuation or Volatility modules.
Neuroone | Research Development | Build AI portfolio with Neuroone Stock |
Analyzing Neuroone Medical's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing Neuroone Medical's current valuation and future prospects.
Latest Neuroone Medical's Research Development Growth Pattern
Below is the plot of the Research Development of Neuroone Medical Technologies over the last few years. It is Neuroone Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neuroone Medical's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Neuroone Research Development Regression Statistics
| Arithmetic Mean | 2,400,030 | |
| Geometric Mean | 334,090 | |
| Coefficient Of Variation | 99.96 | |
| Mean Deviation | 2,113,129 | |
| Median | 1,529,189 | |
| Standard Deviation | 2,398,963 | |
| Sample Variance | 5.8T | |
| Range | 6.9M | |
| R-Value | 0.87 | |
| Mean Square Error | 1.5T | |
| R-Squared | 0.76 | |
| Slope | 413,278 | |
| Total Sum of Squares | 92.1T |
Neuroone Research Development History
About Neuroone Medical Financial Statements
Neuroone Medical stakeholders use historical fundamental indicators, such as Neuroone Medical's Research Development, to determine how well the company is positioned to perform in the future. Although Neuroone Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Neuroone Medical's assets and liabilities are reflected in the revenues and expenses on Neuroone Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Neuroone Medical Technologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 5.7 M | 3.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Neuroone Medical Tec offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neuroone Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neuroone Medical Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neuroone Medical Technologies Stock:Check out the analysis of Neuroone Medical Correlation against competitors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Will Health Care Equipment & Supplies sector continue expanding? Could Neuroone diversify its offerings? Factors like these will boost the valuation of Neuroone Medical. Anticipated expansion of Neuroone directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neuroone Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.16) | Revenue Per Share | Quarterly Revenue Growth 1.054 | Return On Assets | Return On Equity |
The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Neuroone Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Neuroone Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Neuroone Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.